The article discusses Andras Kulja, a Tisza Party MEP, who frequently meets with pharmaceutical lobbyists in Brussels. Despite suffering a defeat in a debate, Kulja engages with major pharmaceutical companies like Sanofi and Pfizer regarding EU health legislation reforms, including the Biotech Act and the Critical Medicines Act. The article questions the transparency of these interactions and the influence of corporate interests on political decisions. Teljes cikk (Magyarnemzet)